Results 171 to 180 of about 353,661 (250)

Dyslipidaemia, Chronic Kidney Disease and Diabetes Mellitus: A Triple Threat to Cardiovascular Health

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 10961-10976, December 2026.
ABSTRACT Diabetes mellitus (DM) and chronic kidney disease (CKD) frequently coexist and together create a ‘triple threat’ with dyslipidaemia, enhancing the risk for cardiovascular morbidity and mortality. Diabetic kidney disease (DKD) leads to altered lipid metabolism through insulin resistance, inflammation and oxidative stress resulting in an ...
Ann S. Forrest   +3 more
wiley   +1 more source

Predicting the Long‐Term Risk of Type 2 Diabetes and Cardiovascular Disease With Orforglipron in People With Overweight or Obesity: A Post Hoc Analysis of the ATTAIN‐1 Trial

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 11452-11462, December 2026.
ABSTRACT Objective To assess change in long‐term predicted 10‐year cardiometabolic risk (Type 2 diabetes [T2D] and cardiovascular disease [CVD]) in adults with overweight or obesity without T2D. Methods This post hoc analysis used data from ATTAIN‐1, a Phase 3 trial in adults (≥ 18 years) with obesity (BMI ≥ 30 kg/m2) or overweight (BMI ≥ 27 kg/m2 with
Shraddha Shinde   +10 more
wiley   +1 more source

InflaMix Predicts Severe CRS, ICU Admission, and Progression‐Free Survival After CAR‐T Therapy in LBCL

open access: yesEuropean Journal of Haematology, Volume 117, Issue 6, Page 1630-1636, December 2026.
ABSTRACT Objectives Baseline systemic inflammation has emerged as a determinant of outcome after CD19‐directed CAR‐T therapy. We evaluated the prognostic performance of the recently developed INFLAmmation MIXture Model (InflaMix) in an independent bicentric cohort of patients with large B‐cell lymphoma (LBCL) receiving commercial CAR‐T cells, focusing ...
Eugenio Galli   +10 more
wiley   +1 more source

The Boron–Neuron Connection: The Potential of Boron‐Containing Molecules for Treating Incurable Amyotrophic Lateral Sclerosis

open access: yesChemMedChem, Volume 21, Issue 21, 12 November 2026.
Can a single element help address the multifactorial nature of ALS? Boron‐containing compounds combine responsiveness to reactive oxygen species (ROS), neuroprotective activity, and favorable pharmacological properties, offering a distinctive framework for disease modification in a complex disease like ALS.
Nitesh Sanghai   +5 more
wiley   +1 more source

Inflammatory and Insulin Resistance Indicator for Predicting Repeat Revascularization and In‐Stent Restenosis in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention

open access: yesClinical Cardiology, Volume 49, Issue 11, November 2026.
In patients with chronic coronary syndrome undergoing PCI, higher baseline CTI was independently associated with repeat revascularization and in‐stent restenosis. However, its incremental predictive value beyond conventional risk factors was limited, highlighting the need for further validation.
Wang Jiale   +3 more
wiley   +1 more source

White Blood Cell Count Is Associated With Hospitalisation for Heart Failure in Patients With ATTR Cardiac Amyloidosis

open access: yesClinical Cardiology, Volume 49, Issue 11, November 2026.
Increased white blood cell (WBC) count was associated with incidence of heart failure hospitalisation in patients with transthyretin amyloid cardiomyopathy (ATTR‐CM), indicating a potential for inflammatory biomarkers in disease monitoring. ABSTRACT Aims and Background Transthyretin amyloid cardiomyopathy (ATTR‐CM) is the most common form of cardiac ...
Elias Haj‐Yehia   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy